Practical AI in Healthcare

S1, E34 - Matt Truppo, PhD, Part 2: AI-Driven Drug Development at Sanofi: Clinical Trials, Regulatory, and Personal AI

56 min · 26. april 2026
episode S1, E34 - Matt Truppo, PhD, Part 2: AI-Driven Drug Development at Sanofi: Clinical Trials, Regulatory, and Personal AI cover

Beskrivelse

In Part 2 of our conversation with Matt Truppo, Global Head of Research Platforms and Computational R&D at Sanofi, we move from discovery to development, where the real stakes begin. Matt unpacks the promise and limitations of “digital patient twins,” a concept often described as the holy grail of drug development. With nearly 90% of drugs failing in clinical trials, even modest gains in predicting efficacy or patient response could transform the industry. Through real-world examples, including Dupixent and rare disease therapies, Matt shows how quantitative systems pharmacology (QSP) and AI-driven simulations are already shortening timelines, reducing patient burden, and, in some cases, eliminating the need for entire trials. But the story doesn’t stop at modeling. We explore how AI is reshaping clinical operations, from Sanofi’s “clinical control tower” that integrates trial data across 4,000 users, to generative AI tools that are cutting regulatory document creation time by more than a third. Matt also shares a personal experiment, building a network of AI agents modeled on his own workflow, reclaiming 30% of his time and offering a glimpse into a more “agentic” future of work. The throughline is clear: AI is not replacing human expertise, but amplifying it, helping the industry finally bend the cost and time curve of drug development.

Kommentarer

0

Vær den første til å kommentere

Registrer deg nå og bli medlem av Practical AI in Healthcare sitt community!

Prøv gratis

Prøv gratis i 14 dager

99 kr / Måned etter prøveperioden. · Avslutt når som helst.

  • Eksklusive podkaster
  • 20 timer lydbøker i måneden
  • Gratis podkaster

Alle episoder

41 Episoder

episode S1, E40 - Jeff Smith — AI Regulation, Transparency & Innovation from the Government Perspective cover

S1, E40 - Jeff Smith — AI Regulation, Transparency & Innovation from the Government Perspective

What happens when the rules for getting AI into clinical care are written by someone who has spent his career inside both the advocacy world and the government? In this episode, we talk with Jeff Smith of ONC at HHS, the first government official on Practical AI in Healthcare. Smith walks us through ONC's proposed HTI-5 rule, including a striking move to treat AI agents as "users" with the same data-access rights as clinicians, and a new question about whether blocking data from being written back into the EHR is itself information blocking. We also dig into the limits of what a regulator can actually do, and why the real work is coordination across agencies rather than control from any one of them. https://practicalaiinhealthcare.com/ [https://practicalaiinhealthcare.com/] https://www.youtube.com/@PracticalAIinHealthcare [https://www.youtube.com/@PracticalAIinHealthcare]

I går43 min
episode S1, E39 - Sarah Rossetti, RN, PhD: Nursing Informatics & the CONCERN Early Warning System cover

S1, E39 - Sarah Rossetti, RN, PhD: Nursing Informatics & the CONCERN Early Warning System

On National Nurses Day, Practical AI in Healthcare welcomes its first nurse: Sarah Rossetti, RN, PhD, of Columbia University. Her CONCERN early warning system takes an unusual approach to predicting patient deterioration. Instead of modeling a patient's vital signs and labs, it models the nurse's documentation behavior, since the frequency and timing of charting reflect clinical concern long before the numbers move. In a 74-unit randomized trial of more than 60,000 patients, published in Nature Medicine, CONCERN was associated with a 35.6% reduction in instantaneous mortality risk. Rossetti and the hosts unpack the method, the counterintuitive rise in ICU transfers, equity safeguards, and what ambient AI means for the signal. https://practicalaiinhealthcare.com/episodes/#S1E39 [https://practicalaiinhealthcare.com/episodes/#S1E39] More on Sarah Rossetti's work: https://www.dbmi.columbia.edu/profile/sarah-collins-rossetti/ [https://www.dbmi.columbia.edu/profile/sarah-collins-rossetti/]

31. mai 202653 min
episode S1, E38 - Reflections 5: How Specialized Does AI Have to Be to Actually Work? cover

S1, E38 - Reflections 5: How Specialized Does AI Have to Be to Actually Work?

In their fifth Reflections episode, Steve and Leon look back across six conversations (Matt Truppo at Sanofi, Ted Shortliffe, Barry Chaiken, David Hidalgo-Gato, and Danny van Leeuwen) to ask a sharper question: how specialized does AI have to be to actually work? The throughline is depth. The LLM is a commodity, and so, increasingly, is the generalist agent. What stays scarce is specialization in a workflow, the revival of symbolic methods like knowledge graphs, the literacy that separates an AI's ~95% solo accuracy from the under-35% people get using it themselves, and leaders willing to use themselves as the test rig. After 37 episodes, the technology is no longer the question. The specificity of the work around it is.

24. mai 202634 min
episode S1, E36 - David Hidalgo-Gato, Founder & CEO, Cleo Health: Going a Mile Deep on Emergency Medicine — Specialization, Design Partnerships, and the Acute Care OS cover

S1, E36 - David Hidalgo-Gato, Founder & CEO, Cleo Health: Going a Mile Deep on Emergency Medicine — Specialization, Design Partnerships, and the Acute Care OS

David Hidalgo-Gato is the founder and CEO of Cleo Health. While more than 100 competitors were building generic ambient AI scribes, David's team chose emergency medicine and stayed with one design partner for nine months and roughly 50 product iterations before launching. The result: an average 54-minute time savings per shift, a patient-assignment tool that turned a four-hour process into 15 to 20 minutes, and use across 400+ hospitals nationwide. The conversation covers why ED workflow breaks generic ambient scribes, why generative AI fits patient assignment specifically, and David's argument that workflow understanding is the moat AI cannot commoditize. https://practicalaiinhealthcare.com/ [https://practicalaiinhealthcare.com/]

10. mai 202649 min